Michael J. Baine, Ph.D.
Affiliations: | 2012 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Oncology, ImmunologyGoogle:
"Michael Baine"Parents
Sign in to add mentor| Surinder K. Batra | grad student | 2012 | University of Nebraska Medical Center | |
| (Immune-Based Novel Diagnostic Mechanisms for Pancreatic Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Amin S, Baine M, Lin C. (2023) Immunotherapy plus stereotactic body radiation therapy or whole-brain radiation therapy in brain metastases. Immunotherapy. 15: 163-174 |
| Amin SA, Baine MJ, Rahman I, et al. (2022) The Association of Immunotherapy With the Overall Survival of Inoperable Stage III Non-small Cell Lung Cancer Patients Who Do not Receive Chemoradiation. Journal of Immunotherapy (Hagerstown, Md. : 1997) |
| Zhang C, Wu R, Smith LM, et al. (2021) An evaluation of adjuvant chemotherapy following neoadjuvant chemotherapy and resection for borderline resectable and locally advanced pancreatic cancer. American Journal of Surgery |
| Wong J, Baine M, Wisnoskie S, et al. (2021) Effects of interobserver and interdisciplinary segmentation variabilities on CT-based radiomics for pancreatic cancer. Scientific Reports. 11: 16328 |
| McLaughlin MF, Alam M, Smith L, et al. (2020) Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer. Plos One. 15: e0241505 |
| Amin S, Baine MJ, Meza JL, et al. (2020) The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database. Frontiers in Oncology. 10: 1518 |
| Ernani V, Appiah AK, Baine MJ, et al. (2020) The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy. Cancer Treatment and Research Communications. 24: 100197 |
| Amin S, Baine M, Meza J, et al. (2020) The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor. Clinical and Translational Radiation Oncology. 24: 34-40 |
| Amin S, Baine M, Meza J, et al. (2020) The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis. Bmc Cancer. 20: 538 |
| Amin S, Baine M, Meza J, et al. (2020) The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database. Radiation Oncology (London, England). 15: 139 |